Agile Therapeutics, Inc.
AGRX
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -11.87M | 1.28M | -4.47M | -798.00K | -3.81M |
| Total Depreciation and Amortization | 102.00K | 103.00K | 100.00K | 98.00K | 95.00K |
| Total Amortization of Deferred Charges | 0.00 | 135.00K | 225.00K | 252.00K | 279.00K |
| Total Other Non-Cash Items | 9.44M | -3.87M | 1.49M | -3.09M | -1.19M |
| Change in Net Operating Assets | 2.57M | -128.00K | 2.82M | 3.90M | -3.89M |
| Cash from Operations | 233.00K | -2.48M | 172.00K | 365.00K | -8.52M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | -1.84M | -488.00K | -348.00K | -286.00K |
| Issuance of Common Stock | 0.00 | 4.38M | 1.00K | 70.00K | 7.16M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 2.54M | -487.00K | -278.00K | 6.88M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -1.00K | 1.00K | -- |
| Net Change in Cash | 233.00K | 59.00K | -316.00K | 88.00K | -1.64M |
